Skip to Content

China Life Insurance: NBV Growth Ahead of Expectation, Agent Headcount Stable

""

Following largely in-line results, we retain our fair value estimate for China Life 601628 at CNY 19 per A share and HKD 20 per H share. With the H shares trading at a sharp discount to the A shares, we prefer the H share over the expensive A share. First-half new business value, or NBV, growth increased to 19.9% year on year from the 7.7% growth in the first quarter, beating our expectation for about 15.0% growth. NBV growth was driven by the 13% and 122% respective year-on-year growths in agent and bancassurance channels, as customers rushed to buy the last batch of high-yield savings products before the pricing rate cut in end-July.

Similar to peers, first-year premium accelerated to 23% year on year, but we expect premium growth to moderate in the third quarter after the recent July pricing rate cut. Despite a stronger-than-expected first-half NBV growth, we expect the second half NBV growth to moderate along with slowing premium growth. However, the stable agent headcount and NBV margin should be able to support a double-digit growth in NBV for 2023. Agent headcount has largely stabilized from the March level at around 660,000. First-half NBV margin was largely flat at 30.2%, compared with the 30.4% in the year-ago period. We estimate NBV per agent improved over 30% year on year.

First-half net profits under old accounting rules were volatile, declining 36% year on year on CNY 12.8 billion in asset impairment losses related to unfavorable stock market performance and CNY 5.9 billion reduction due to a change in actuarial assumptions and lower government bond yield. In line with our expectations, the IFRS 17- and IFRS 9-based net profit declined 8% year on year to CNY 36.151 billion. We suspect the lower earnings volatility was mainly due to the expenses related to the insurance liability reserve on lower 10-year government bond yield and the change in noneconomic assumptions were absorbed by contractual service margin, which did not impact profit and loss.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Iris Tan

Senior Equity Analyst
More from Author

Iris Tan, CFA, is a senior equity analyst for Morningstar (Shenzhen) Ltd., a wholly owned subsidiary of Morningstar, Inc. She covers banking, insurance, and property companies in China.

Before joining Morningstar in 2006, she was a financial analyst for San Miguel Brewery and a research assistant for GTA Information Technology.

Tan holds a master’s degree in finance from the University of Strathclyde. She also holds the Chartered Financial Analyst® designation.

Sponsor Center